Top Federal Drug Official Personally Hesitates To Study Marijuana Because Of Schedule I Research Barriers

Marijuana Moment
By Kyle JaegerDec 2, 2021, 8:13 am181 pts
The top federal drug researcher says even she is reluctant to conduct studies on Schedule I drugs like marijuana because of the “cumbersome” rules that scientists face when investigating them. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), made the comments during a Wednesday forum…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Licensed New York Cannabis Retailers File Lawsuit Against Office of Cannabis Management 77

Controversial Michigan marijuana testing lab run by former cops must close 66

Florida medical marijuana patients can use guns, court rules 65

UFCW seeks to organize workers at Organigram 61

TEDCO Invests in Leading DMV Logistical Software, Health Care Tech Company 54

U.S. Senate Committee To Hold Hearing On Benefits Of Psychedelics For Military Veterans 51

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.